Correlation of native T1 mapping with right ventricular function and pulmonary haemodynamics in patients with chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty

[11] Agnelli G(1982)Longterm follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data Chest 81 151-158

[12] Pesavento R(2001)Prognostic factors in medically treated patients with chronic pulmonary embolism Chest 119 818-823

[13] Pengo V(2009)Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 43-54

[14] Lensing AW(2011)Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry J Thorac Cardiovasc Surg 141 702-710

[15] Prins MH(2014)Chronic thromboembolic pulmonary hypertension (CTEPH)—potential role of multidetector-row CT (MD-CT) and MR imaging in the diagnosis and differential diagnosis of the disease Rofo 186 751-761

[16] Klok FA(2013)CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension N Engl J Med 369 319-329

[17] van Kralingen KW(2015)Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2) Eur Respir J 45 1293-1302

[18] van Dijk AP(2016)Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial Lancet Respir Med 4 372-380

[19] Heyning FH(2017)Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience Eur Resp J 49 6-X43

[20] Vliegen HW(2016)Percutaneous treatment of chronic thromboembolic pulmonary hypertension (CTEPH) EuroIntervention 12 X35-554

[11] Agnelli G(1982)Longterm follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data Chest 81 151-158

[12] Pesavento R(2001)Prognostic factors in medically treated patients with chronic pulmonary embolism Chest 119 818-823

[13] Pengo V(2009)Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 43-54

[14] Lensing AW(2011)Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry J Thorac Cardiovasc Surg 141 702-710

[15] Prins MH(2014)Chronic thromboembolic pulmonary hypertension (CTEPH)—potential role of multidetector-row CT (MD-CT) and MR imaging in the diagnosis and differential diagnosis of the disease Rofo 186 751-761

[16] Klok FA(2013)CHEST-1 Study Group. Riociguat for the treatment of chronic thromboembolic pulmonary hypertension N Engl J Med 369 319-329

[17] van Kralingen KW(2015)Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2) Eur Respir J 45 1293-1302

[18] van Dijk AP(2016)Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial Lancet Respir Med 4 372-380

[19] Heyning FH(2017)Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience Eur Resp J 49 6-X43

[20] Vliegen HW(2016)Percutaneous treatment of chronic thromboembolic pulmonary hypertension (CTEPH) EuroIntervention 12 X35-554